Oncology News

Oncology
sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



1. Report Shows Shift in Starting Salaries for Physicians
2. Recommendations on the use of 18F-FDG PET in oncology
3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials
4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer
5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Top Ten Searches

brca1
prostate-specific antigen
sclc
fobt
egd
bmi
dysplasia
hematologic
ovarian
hcc

Your Article Summary

See Latest Articles
(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Double allogeneic hematopoietic SCT as a rescue therapy for poor-risk hematological malignancies
Bone Marrow Transplantation, 07/01/09

Stussi G et al. - The authors have shown the feasibility of dHSCT with an acceptable TRM, irrespective of a previous allogeneic HSCT. Whether this approach offers a survival benefit for patients with poor-risk leukemias has to be tested in larger prospective trials.


Today in BMT/SCT...keeping you current

Combined topical dexamethasone/tacrolimus therapy for management of oral chronic GVHD
Bone Marrow Transplantation, 11/05/09

Allogeneic hematopoietic stem cell transplantation (alloSCT) for chronic myeloid leukemia in the imatinib era; Evaluation of its impact within a subgroup of the randomized German CML Study IV
Blood, 11/20/09

Reduced-intensity conditioned allogeneic haematopoietic stem cell transplantation results in durable disease-free and overall survival in patients with poor prognosis myeloid and lymphoid malignancies: Eighty-month follow-up
Bone Marrow Transplantation, 11/13/09

See All of BMT/SCT

Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address